These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30661467)

  • 21. IMPAIRED ENDOTHELIAL FUNCTION IN PEDIATRIC HEMOGLOBIN E/β-THALASSEMIA PATIENTS WITH IRON OVERLOAD.
    Aphinives C; Kukongviriyapan U; Jetsrisuparb A; Kukongviriyapan V; Somparn N
    Southeast Asian J Trop Med Public Health; 2014 Nov; 45(6):1454-63. PubMed ID: 26466432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of vitamin E on platelet activity in beta-thalassaemia patients.
    Unchern S; Laoharuangpanya N; Phumala N; Sipankapracha P; Pootrakul P; Fucharoen S; Wanachivanawin W; Chantharaksri U
    Br J Haematol; 2003 Nov; 123(4):738-44. PubMed ID: 14616980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paraoxonase and platelet-activating factor acetylhydrolase activities in lipoproteins of beta-thalassemia/hemoglobin E patients.
    Phumala Morales N; Cherlermchoung C; Fucharoen S; Chantharaksri U
    Clin Chem Lab Med; 2007; 45(7):884-9. PubMed ID: 17617032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative proteomics of plasma vesicles identify novel biomarkers for hemoglobin E/β-thalassemic patients.
    Kittivorapart J; Crew VK; Wilson MC; Heesom KJ; Siritanaratkul N; Toye AM
    Blood Adv; 2018 Jan; 2(2):95-104. PubMed ID: 29365317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxyurea for hemoglobin E/β-thalassemia: a systematic review and meta-analysis.
    Algiraigri AH; Kassam A
    Int J Hematol; 2017 Dec; 106(6):748-756. PubMed ID: 28786080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin E status, glutathione peroxidase activity and the effect of vitamin E supplementation in children with thalassemia.
    Suthutvoravut U; Hathirat P; Sirichakwal P; Sasanakul W; Tassaneeyakul A; Feungpean B
    J Med Assoc Thai; 1993 Oct; 76 Suppl 2():146-52. PubMed ID: 7822984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined chelation therapy with daily oral deferiprone and twice-weekly subcutaneous infusion of desferrioxamine in children with β-thalassemia: 3-year experience.
    Songdej D; Sirachainan N; Wongwerawattanakoon P; Sasanakul W; Kadegasem P; Sungkarat W; Chuansumrit A
    Acta Haematol; 2015; 133(2):226-36. PubMed ID: 25376266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of oral iron chelating agent deferiprone in beta-thalassemia and hemoglobin E-beta thalassemia.
    Adhikari D; Roy TB; Biswas A; Chakraborty ML; Bhattacharya B; Maitra TK; Basu AK; Chandra S
    Indian Pediatr; 1995 Aug; 32(8):855-61. PubMed ID: 8635827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of deferiprone in patients with β-thalassaemia: impact of splenectomy and iron status.
    Limenta LM; Jirasomprasert T; Jittangprasert P; Wilairat P; Yamanont P; Chantharaksri U; Fucharoen S; Morales NP
    Clin Pharmacokinet; 2011 Jan; 50(1):41-50. PubMed ID: 21028920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of deferiprone and deferasirox on the structure and function of beta-thalassemia hemoglobin.
    Moosavi-Movahedi AA; Mousavy SJ; Divsalar A; Babaahmadi A; Karimian K; Shafiee A; Kamarie M; Poursasan N; Farzami B; Riazi GH; Hakimelahi GH; Tsai FY; Ahmad F; Amani M; Saboury AA
    J Biomol Struct Dyn; 2009 Dec; 27(3):319-39. PubMed ID: 19795915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in beta-thalassemia/Hb E.
    Luechapudiporn R; Morales NP; Fucharoen S; Chantharaksri U
    Clin Chem Lab Med; 2006; 44(5):574-81. PubMed ID: 16681427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three most common nonsynonymous UGT1A6*2 polymorphisms (Thr181Ala, Arg184Ser and Ser7Ala) and therapeutic response to deferiprone in β-thalassemia major patients.
    Dadheech S; Rao AV; Shaheen U; Hussien MD; Jain S; Jyothy A; Munshi A
    Gene; 2013 Dec; 531(2):301-5. PubMed ID: 24036429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children with hemoglobin E/β-thalassemia have a high risk of being vitamin D deficient even if they get abundant sun exposure: a study from Thailand.
    Nakavachara P; Viprakasit V
    Pediatr Blood Cancer; 2013 Oct; 60(10):1683-8. PubMed ID: 23733667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased oxidative metabolism is associated with erythroid precursor expansion in β0-thalassaemia/Hb E disease.
    Leecharoenkiat A; Wannatung T; Lithanatudom P; Svasti S; Fucharoen S; Chokchaichamnankit D; Srisomsap C; Smith DR
    Blood Cells Mol Dis; 2011 Oct; 47(3):143-57. PubMed ID: 21783389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dysregulation of ferroportin gene expression in β(0)-thalassemia/Hb E disease.
    Sornjai W; Jaratsittisin J; Khungwanmaythawee K; Svasti S; Fucharoen S; Lithanatudom P; Smith DR
    Ann Hematol; 2016 Feb; 95(3):387-96. PubMed ID: 26666535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of hepcidin expression by normal control and beta0-thalassemia/Hb E erythroblasts.
    Jaratsittisin J; Sornjai W; Svasti S; Fucharoen S; Roytrakul S; Smith DR
    Hematology; 2018 Aug; 23(7):423-428. PubMed ID: 29157161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
    Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Free Radic Res; 2018 Jan; 52(1):70-79. PubMed ID: 29207893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of deferiprone and deferrioxamine for the treatment of transfusional iron overload in children with beta thalassemia major.
    Waheed N; Ali S; Butt MA
    J Ayub Med Coll Abbottabad; 2014; 26(3):297-300. PubMed ID: 25671931
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative Proteome-Wide Analysis of Bone Marrow Microenvironment of β-Thalassemia/Hemoglobin E.
    Ponnikorn S; Mongkolrob R; Klongthalay S; Roytrakul S; Srisanga K; Tungpradabkul S; Hongeng S
    Proteomes; 2019 Feb; 7(1):. PubMed ID: 30813444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coenzyme Q10 levels in β-thalassemia and its association with ferritin levels and chelation therapy.
    Karakukcu C; Karakukcu M; Unal E; Patiroglu T; Ozdemir MA; Torun YA; Tang PH
    Hemoglobin; 2012; 36(3):219-29. PubMed ID: 22483337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.